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Summary: Lymph is the minute net volume of contending hydrostatic and osmotic capillary forces. It is built
up extravasculary in tissues and reaches the intravasal space by definite lymph collecting vessels, which enter
the venous System at the angulus venosus at the root of the neck. Sampling methods for lymph from individual
tissues or from lymph collecting vessels of man and various animals afe cited and the preparation of lymph for
enzymatic analysis is described. The extracellular distribution and transport of enzymes is important for diag-
nostic enzymology, because enzymes released from cells in continuous physiological processes, or after injury
to the tissue, reach the intravasal space mainly via the lymphatics. This is evident from the high lymph-plasma
ratios of diagnostically important enzymes. The type of enzyme transport (lymphatic or by direct interstitial-
venous entry) depends on the heterogeneity of the capillary barrier characteristic of the different organs. The
permeability is extremely high in liver, i.e. enzymes in hepatic lymph originale mainly from blood, which they
have reached through the large openings in the sinusoidal endothelial lining; in contrast the permeability is
extremely low in skeletal muscle, where lymphatic transport therefore predominates. The phenömenon of
increased enzyme activities in plasma after physical exertion is explained by alterations of lymph flow. A table
gives a survey of enzyme activities, lymph-plasma quotients, and lymph flow from lymph vessels of various
tissues äs well äs from the lymph collecting vessels of man and animals, with comments on the significance for
diagnostic enzymology.
Enzyme in der Lymphe: Eine Übersicht
Zusammenfassung: Lymphe ist das in Geweben extravasal im Widerstreit hydrostatischer und osmotischer
kapillarer Kräfte gebildete Flüssigkeitsvolumen und wird über definierte Lymphsammelgefäße dem Intrava-
salsystem im Venenwinkel am Hals mündend, wieder zugeführt. Techniken der Gewinnung von Lymphe als
definierte^Organlymphe oder aus Lymphsammelgefäßen bei Mensch und Tier werden zitiert und ihre Aufbe-
reitung für die enzymatische Analyse beischrieben. Die Bedeutung der Transport- und Verteilungsfunktion
von Enzymen über die Lymphe für die diagnostische Enzymologie erklärt sich daraus, daß Enzyme, die
kontinuierlich als physiologischer Prozeß oder nach Schädigung des Gewebes aus Zellen austreten, den Intra-
vasalraum vorwiegend über die Lymphe erreichen, was sich in hohen Lymph-Plasma Aktivitätsverhältnissen
von diagnostisch verwertbaren Enzymen ausdrückt. Die Art des Enzymtransports — direkt interstitiell-venös
oder lymphatisch — hängt von dem verschiedenartigen kapillaren Bamereverhalten in den unterschiedlichen
Organen ab. Die Permeabilität ist extrem hoch in der Leber, d.h. Enzyme in der Leberlymphe stammen
überwiegend aus dem Blut, das sie über direkten sinusoidalen Zugang erreicht haben; und die Permeabilität
ist extrem niedrig in der Skelettmuskulatur, d.h. hier dominiert der lymphatische Transport. Die nach körper-
licher Belastung im Plasma zu beobachtenden Enzymaktivitätsveränderungen werden über Lymphflußände-
rungen erklärt. Eine tabellarische Übersicht informiert über die in Lymphgefäßen verschiedenster Gewebe
und Lymphsammelgefäßen bei Mensch und Tier bestimmten Enzymaktivitäten, die Lymph-Plasmaquo-
tienten und Lymphflüsse aus diagnostisch-enzymologischer Sicht.
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1. Lymph Formation
According to the classical Starling-Landis concept,
lymph is the minute net volurne of the capillary fluid
balance, maintained by a dynamic interaction of hy-
drostatic and osmotic forces acting across the capil-
lary wall.
These forces are considered to be of almost equal
magnitude, therefore cancelling each other out (1).
The mechanisms concerned in the formation of
lymph have been critically debated (2). However,
there has evolved over the years a concept which has
been fairly generally accepted. It embraces the view
that lymph from any tissue (except kidney medutia
and choroid plexus, which lack lymph vessels) con-
tains all the proteins that can be detected in plasma
andrthat lymphatic vessels are, in general, essential
for the continual movement of these proteins in öne
direction throughout the extracellular flüid of the
body - from plasma to tissue fluid to lymph and
back to/ the plasma (3).
It has been proposed that materials are transported
across capillary walls by different mechanisms: con-
vection, permeation (diffusion), pinocytosis, filtra^·
tion, escape through small and lafge pores (leaks) or
accompanying the passage of recirculating lympho-
cytes through the post-capillary venules in the lymph
node; the type of transport that predominates de-
pends on the heterogeneity of the barrier character^
istics of the different organs (4-12).
Tfte tränscapillary escape rates correlate inversely
with the molecular weights of the proteins. The ex^
travascular return rate reflects the lymphatic protein
transport and is the reciprocal of the extravascular
transit time, which covers a wide ränge: shprt in liv-
er, kidney and lüngs and long (up to 5—6 days) in
muscle and skin (13).
It is, however, a controversial whether or not a pro-
tein, once it has entered the extravascuilär spaee, eäjn
gain access to the circulating blood except by way of
the lymphatics äs stated by Lassen et aL (9).
For skeletal muscle and subcütis Noer & Lasseh (6)
propose that escape is negligible, i.e. that maximally
1% of the interstitial albumin can undergo local
transendothelial escape by passive forces, such äs
diffusion and pinocytosis. Experimental findings and
theoretical considerations (4), however, are cpmpati-
ble with an uphill albumin transport (14) at least in
liver, kidney and skeletal muscle (5).
Nevertheless it can be stated that lymph flow is
essary for the removal of proteins. Otherwise their
cöncentrations woüld rise progprössively in the inter^
stitium and lead to an excessive filtration of fluid. In
terms of total volume flow, however, lymph flux may
represent only a small corrective process that adjusts
the concentration of one type of component in the
interstitium in relätiön to the much möre impoftant
process of transcapillary filtration and eabso tion
(15).
When following the fate of fluid and molecules
which have entered the extravascular space, one has
to consider the physico-chemical properties pf the
interstitial space, which is very inhomogeneous,
Quyton et al. (26, 218) have atteinpted to sjmthesize
a working System for interstitial fluid regulation and
lymph formation: The interstitial fluid spaces are
filled with a mat of collagen fibers, and the intersti-
ces of this mat contain a mueopolysaccharide gel
ground substance, mainly hyaluronic acid. Both the
Collagen fibers arid the gel are elastic structures that
can be expanded or compacted.
In normal tissue, almost of the fluid is in the gel state
and almost none in the free fluid state. In the com-
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pacted state the elastic recoil of the compressed col-
lagen fibers and gel reticular fibrillae seem to cause
suction on the fluid within the tissue spaces, thus
creating a subatmospheric pressure. Measurements
of interstitial fluid pressure indicate that this is nor-
mally slightly negative in most soft tissues.
However, even very slight extra Filtration of fluid in-
to the tissue spaces increases the interstitial fluid
pressure toward more positive values, which in turn
increases lymph flow. The increased lymph flow then
decreases the interstitial fluid volume and pressure,
so that they approach normal values. This occurs by
two mechanisms.
Firstly, the direct removal of fluid from the tissue
spaces in the lymph and secondly, the removal of
protein from the interstitial fluid in the lymph, thus
decreasing the interstitial fluid colloid osmotic pres-
sure and allowing more effective osmosis of fluid di-
rectly from the interstitial spaces back into the capil-
laries.
There is more evidence in support of this theory than
that of Zweifach & Silberberg (15), who propose a
continuous positive pressure gradient for fluid flow
toward the lymphatic capillaries. The generally ac-
cepted subatmospheric interstitial free fluid pres-
sure, however, is not compatible with this concept.
Aside from the possibility of a physical lymphatic
pump, Casley-Smith (16, 17) has also suggested that
an intermittent osmotic effect might also cause
movement of fluid through the pores of the lymphat-
ic capillary.
Collection of interstitial fluid is indispensable in stu-
dies of transcapillary and interstitial transport of
materials and water. Generally, three methods of in-
terstitial fluid sampling may be applied: the capsular
technique developed by Guyton (18, 19), the liquid-
paraffin method described by Haljamäe (20) and the
wick method by Auckland & Fadnes (21). These
findings raise the controversial question of whether
or not lymph is identical with interstitial fluid (l, 22,
23).
Based on recent biochemical and ultrastructural stu-
dies, interstitial fluid exists in two phases, and, de-
pending on the sampling method, different propor-
tions of these two phases may be obtained (15,
24-28).
The general Statement, that all the proteins found in
plasma are also found in lymph, although in lower
concentrations (29) does not hold true for cellular
enzymes. On the contrary, most enzymes are found
in particulary higher activities in lymph than in plas-
ma, an observation that could be anticipated, in view
of the fact that enzymes of cellular origin show a
much higher activity in the intracellular than the ex-
tracellular space.
This extremely high "gradient" on the other side is
cited äs evidence for direct venous entry; and often
the intravascular activity of a particular enzyme is
shown to depend on its molecular weight. The activi-
ty ratio between tissue and plasma or lymph — which
in fact is extremely high — is erroneously equated
with the molar concentration gradient.
Calculation from our data on enzyme concentration
in lymph (30) revealed values between 1.0 to 50
nmol/1 for alkaline phosphatase and creatine kinase,
respectively, äs extreme examples. The correspond-
ing values for muscle tissue are 0.016 and 2000
/kg tissue.
That means that the extracellular concentrations are
negligible and the gradient therefore depends only
on the intracellular enzyme concentration and the
thickness of the cell membrane; even for creatine ki-
nase with its extremely high activity in muscle, the
gradient in fact is very low. For other enzymes and
tissues, respectively, this gradient is at least a
hundred times smaller.
Enzymes in plasma and lymph therefore do not par-
ticipate in the colloid osmotic forces acting at the ca-
pillary.
There is, however, a controversial discussion äs to
whether enzymes from the extracellular space can
reach the intravasal space directly by traversing the
capillary.
The Statement by Lassen et al. (9) müst be men-
tioned again: the back flux of proteins at the micro-
vascular level is negligible; once a protein molecule
has crossed the capillary wall, it will return to the
plasma via the lymph.
From this general formulation, whose limitations
have been discussed above, it is questionable wheth-
er enzymes in heart and muscle reach the intravascu-
lar space directly, äs proposed by several authors
(31-40).
2, Lymph Collecting Vessels
The thoracic duct drains lymph from the abdominal
viscera and lower extremities, the left upper limb,
left side of the head and neck and parts of the heart,
while the right lymphatic duct drains most of the
lungs, heart, serous cavities, right upper extremities
and right side of the head and neck (29, 41—43).
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Compared with these two main lymph Systems, the
lymph flow from the cervical and subclavian lymph
ducts, which also finally enter the intravasal com-
partments at the root of the neck, is small. Thoracic
duct lymph flow in mammals is 1-2 ml/kg · h and
3-5 mlAg · h in ruminants (29), whereas right duct.
lymph flow amounts to only about 5^20% of this
value (29, 41, 44, 45). Hepatic and intestinal lymph
probably make equal contributions to the total
lymph in the thoracic duct (46, 47, 48).
In conscious or excercising animals, however, lymph
flow exceeds the values reported above fqr änaes-
thetized animals by 50 and iiearly 300% respective-
iy-
This increase is probably due in part to enhanced
lymph flow from excercising muscles by the action of
the tissue pump and in part the increased liver lymph
flow due to the increased pressure and massaging efc
fect to the abdominal lymphatics by muscular move-
ment. ^
During anaesthesia and atrest, an extravascular fluid
pool would seem to be accumulated, which is then
emptied during excercise (30, 46* 49, 50, 51).
The driving force for the propulsion of thoracic duct
lymph in the anaesthetized state is the "respiratory
pump", whereas in the conscious state the impor^
tance of the "tissue pump" and "vis a tergo" come to
the fore (52).
3. Sampling Methods for Lymph from Regional
Lymphatics
Detailed descriptions of lymph sampling methods in
man and various animals are given by Yöffey &
Courtice (29) (1970) and by Rusznyak et al. (53)
(1969). Since the appearance of these publications,
the number of definite lymphatics of various animals
and man from which lymph can be collected has
been increased; classical sampling techniques have
been modified or revised, mainly due to newly aväil-
able catheter material. In addition, chronic methods
and shunt-techniques have been developed, which
allow sampling of lymph from conscious probands
under more physiological conditions, thus avoiding
the multifarious disadvantages of fistula-techiiiqües,
such äs the permanent fluid-, protein- and cell loss
(54) and the general reduction of lymph flow under
anaesthesia (49, 52, 55).
The following brief and comprehensive review of
sampling techniques from various lymphatics in man
and the most commonly used animals therefore fo-
cusses mainly on techniques described since 1970.
3.1 Man
The classical technique of thoracicus duct fistula
of Biermän et al. (56) Interrupts the thoracic duct at
the site of cannulation and creates a permanent ex-
ternal end fistula. Detailed descriptions of this kind
of cannulation are also given by Tllney & Murray
(57) and Werner (58).
The "thoracic duct to duct shünt" and "thoracic duct
side fistula", which leave the thoracic duct circula-
tion unimpaired, are outlined' by Liljeqvist et al. (59)
and Girardet & Benninghoff (54, 60). Reviews on
indications and techniques of thoracic duct cannula-
tion in man are given by Lob et al. (61) and Evans &
Holyoke (62).
The right duct lymph has been sampled by Hallen
& Hansson (63).
Based on the normal anatomy of the lymphatic sys-
tem in the human leg (64) a chronic cannulation of
peripheral leg lymph has been wörked öüt by
Engeset et al. (65) and was improved by Olszewski
(24).
3.2 Sheep
The collection of lymph in conscious animals fe-
quires them to be adequately restrained to prevent
them from chewing of pulling out the cännulä. Sheep
are ideal subjects äs they are extremely cooperative
and placid and show no inclination to interfere with
cannulae or collection vessels (66).
The cited authors all used the fistülä technique in
conscious animals. '
Lascelles & Morris (67) describe ductus thoraci-
cus, intestinal and mammary gland cannula-
tion. The preparatioü of chronic lüiig lymph fistu-
las in sheep by Staub et al. (68) has become wide-
spread in investigations on shock. Renal lymph
appeared originale riearly entirely from the renäl
cortex (69, 70).
Hepatic lymph was sampled äccording to Las-
celles & Morris (67) and Smith et al. (70).
Testiculäf lymphatics and lymph from the läc-
tating and non lactating mammary gland were de-
scribed by Cowie et al. (71), Morris & Mclntösh (72)
and Lascelles & Morris (67), respectively. Peripheral
leg lymph was sampled from popliteal (73, 70),
praescapular (70, 74) and praefemoräl lym-
phatics (70, 75).
Surgical techniques for establishing chronic fistulae
in the thoracic duct, intestinal, lumbar and popliteal
lymph duct of fpetal lambs in utero are de-
scribed by Smeaton et al. (76) and for the thoracic
duct alone by Pearson et al. (77). >
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3.3 Dog
The dog is the most commonly used animal in exper-
imental lymphatic research. Investigations on tho-
racic duct and heart lymph are especially numerous.
In the last decade successful attempts were under-
taken to change from classical fistula techniques and
anaesthetized animals to improved methods with
shunt techniques and conscious animals, respective-
ly.
Glauser et al. (44) and Vreim & Okhuda (78) deli-
neate an improved method for the cannulatiön of the
right lymph duct. From the many descriptions of
thoracic duct cannulatiön with an end-fistula, the
simplified and revisited methods of Witte et al. (79)
and Briscoe (80) should be noted. Whereas Nelson
et al. (81) used the fistula technique for long term
catherization, this is now superceded by advanced
techniques that leave the lymph circulation unim-
paired; thus Doemling & Sieggerda (82) and Brown
& Hardenbergh (83) used thoracic duct-venous
shunt preparations, and Girardet & Benninghoff
(84) used thoracic duct to duct shunt and thoracic
duct side fistula. The great variations in the canine
thoracic duct System are demonstrated by Kagan &
Breznock (85).
Helpfull aids for collection of heart lymph are giv-
en by Kluge & Ullal (86) Ullal (87), Ali et al. (88),
Feola & Glich (89) and Leeds & Uhley (90). Michael
et al. (91), however, describe a technique for obtain-
ing cardiac lymph from conscious dogs.
Lung lymph cannulatiön is outlined by Parker et
al. (92). Both hepatic and intestinal lymph was
investigated by Nix et al. (46), Cain et al. (47) and
Grindlay et al. (93).
Methods for differentiation between capsular and hi-
lar renal lymph are given by Key l et al. (94) and
Le Brie (95), respectively. Both sämpling sites are
compared by Bell (96) and O'Morchoe et al. (97).
Colleetion of peripheral leg lymph has been done
by White et al (98), Garlick & Renkin (11) and Joyn-
er et al. (99). The anatomy of the lymphatic trunks in
the dog bind leg is described by Pflug & Calnan
(100).
3.4 Rabbit
Gibson & Segal (101) sampled right duct lymph.
Cannulatiön of the thoracic duct is not äs difficult
äs described by Sanders et al. (102), but it is easier
with the technique of Zilversmit et al. (103). In con-
trast to the cervical approach of these authors, Red-
grave (104) chose an abdominal access at the cyster-
na chyli.
For the collection of lymph from l iverorkidney,
reference should be made to, e.g. Vogel & Stracker
(105) and Courtice (106) or Gärtner et al. (107) and
Vogel & Ströcker (105), respectively; the latter au-
thors also collected lymph from the lumbar t r u n k.
Peripheral leg lymph from different regions was
collected by Roberts & Courtice (108) and Courtice
(109). Examples of cannula Implantation in the fem-
oral lymphatic for acute (110) and chronic purposes
(111) are given.
The same author also describes a method for collect-
ing in u s de lymph separately from that draining
the skin (112).
3.5 Rat
Besides the classical Bollmann technique of thorac-
ic duct end fistula (113,114) a thoracic duct to duct
shunt and a T-tube side thoracic duct fistula is pres-
ented (54), which obviates the constant loss of lymph
attending the Standard Bollmann fistula. In contrast
to the above cited authors, who used an abdominal
approach Reinhardt (115), Saldeen & Linder (116)
and Azargoschasb (117) used a cervical approach at
the site of entrance of the lymph into the junction of
internal jugular and subclavian veins with the left ve-
na cava cranialis.
Descriptions of hepatic and/or intestinal lymph
sämpling are given by Bollman et al. (113), Fried-
man et al. (118) Warshaw (119) and Lee (219).
Dennhardt & Gartemann (120) developed an exteri-
orized intestinal lymphatic-vena cava shunt. The
anatomical arrangement of renal and systemic lym-
phatics are shown in figures by Sakai et al. (121) and
Hargens et al. (122).
After resuscitation from anaesthesia, the rats can be
restrained in a cage, which limits the activity (123),
for long term sämpling of lymph from different sites
in conscious animals.
3.6 Mouse
Techniques for collecting thoracic duct lymph by
a abdominal approach in conscious mice are de-
scribed by Shrewsbury (124), Boak & Woodruff
(125), Gesner & Gowans (126) and Deaton (127),
Morse & Riester (220) and Mandel (221). A cervical
approach to thoracic duct lymph in mice has recently
been outlined by our group (222).
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4. Preparation of Lymph for Enzyme Activity De-
termination
It is advisible to add an anticoagulant, because
lymph contains all coagulation factors and compo-
nents of the fibrinolytic System. Although the lymph
does not contain any thrombocytes, thromboplastin
formation is sufficient for clot formation (128, 129,
130).
Lymph contains a high level of leukocytes, and smäll
contaminations of erythrocytes (29, 131). In view of
the high intracellular enzyme activity of these cells
(132, 133), lymph must be centrifuged.
Storage of lymph plasma at —70 °C causes no loss in
activity, at least for those enzymes measured by our
groups (30, 51, 134, 135), but systematic studies on
changes of activity in lymph kept at different
temperatures, are lacking.
Lipaemic intestinal or thoracic duct lymph can easy
be clarified by üsing an Airfuge Ultracentrifuge with
the rotor ACR-90 (Beckman Instruments), by flota-
tion of the chylomicrons after 10 min of centrifuga-
tion at 107000 g. Frigen (Hoechst), which is also
used to clarify lipaemic serum and which does not
interfere with enzyme activity in plasma (136) can
also be used.
5. Significance of Extracellular Distribution and
Transport of Enzymes for Diagnostic Enzymology
Enzymes released from cells, äs the result of physio-
logical processes of cell-turnover or due to a patho-
logical event, can reach the circulating blood on
three different ways. If the cells of origin are in direct
contact with the blood, such äs blood cells or the en-
dothelial cells of the blood vessels, the released en-
zymes are rapidly distributed all over the intravasäl
space, so that the extent of the initial dilution de-
pends on the plasma volume. If the cells of origin
have direct contact with the interstitial äs well äs to
the intravascular space and/or if the capillary per-
meability of that region is high (e.g. liver and spieen)
the released enzymes are again rapidly distributed all
ovfer the intravascular compartment, but in addition
they also become distributed in parts of the intersti-
tial compartment and the lymphatic Systems. If the
cells of origin are in direct contact with the intersti-
tiai space only and/or the permeability of the capil-
lary membranes is low (e.g. skeletal muscle), the re-
leased enzymes reach the intravasäl compartment
preferably by lymphatic transport and hardly at all
by direct interstitial-venous entry. Because of the
time-consuming lymphatic transport, the time course
of appearence of enzymes in plasma lags behind the
interstitial-lymphatic increase.
It is atmost iinpossible to experimentally accomplish
an isolated and controlled elevation of enzyme activ-
ities in the interstitial compartment' which woüld be
necessary for the quantitative investigatipn of extra-
cellular enzyme transport. All öne can do is to injure
a limited region of tissue, whpse cells have no direct
contact with the intravascular space.
According to reported data (5, 137, 138, 139), peri-
pheral skeletal muscle is a tissue with a particular
low capillary pernieability. Furthermore, skeletal
muscle offers the great advantage that, in cpntrast to
ottier orgafts, the rate of outflowing lymph can easily
be influenced by changes in its physical activity (39,
46, 49, 140, 141).
If enzyme released from muscle cells, reach the in-
travascular compartment exclusively by lymphatic
transport, damage to muscle cells should be detecta-
ble by measurement of enzyme activities in blood
plasma only if the lymph flow from the respective
region can be maintained.
Lymph flow from muscle is mainly ä fuiictioii of
muscular activity: it stagnates completely with im-
mobility and is stimulated by active äs well äs passive
motion (50, 98, 142).
Consequeiitly an injury tö cells of skeletal muscle,
kept immobile, should not result in an increase of
enzyme activities in blood plasma. These considera-
. tions are strongly supported by experimental find-
ings of our gröup.
In anaesthetized dogs one limb was rnade hyppxic by
clampiiig the fenioral artery for one hour and en-
zyme activities were fpllpwed thereäfter for several
hours in thoracic duct lymph (51), truncus lumbajis
lymph (30) and pefipheral leg lymph (135).
It was proven beyond any doubt, that enzymes from
skeletal muscle are tfanspofted from the intefstitial
into the intravascular compartment mainly by lym-
phatic träiispört.
Indications were found that the Interruption of blood
flow to skeletal muscle for one hour did not result in
an enzyme release from muscle cells. The lymphatic
pathway, however, is called in question by Bolter &
Critz (39, 40) and Szabo et al. (36, 37, 38).
The experimental design pf these gfoüps, however,
who provoked active motion of muscle by electrical
Stimulation, seems to be fär beyPiid any physiologi^
cal condition, in particular because of the high fre-
quency (8-10 s"1) and amplitude (50-70 V) of the
stimula they used. **
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Friedel (143) pointed out the practical importance of
lymph flow and its impairment by comparisoii of
creatine kinase activities in plasma after myocardial
infarction and lesions to skeletal muscle.
Although the latter contains nearly 10 times more
creatine kinase than the myocardial muscle, even se-
vere lesions do not result in the distinct elevations of
enzyme activity that are observed after a myocardial
infarction. The explanation for this obvious discre-
pancy seems very simple: The injured muscle will be
reflectively kept immobile which results in a Stagna-
tion of lymph flow.
The enzymes released from injured cells remain in
the interstitial space because there is no way of
transportation. After myocardial infarction, howev-
er, lymph flow does not cease, because most parts of
the muscle are still working, and enzymes are trans-
ported by this route. The lymphatic transport ac-
counts for 15—50% of the totally released enzymes
(31—35), whereas the greater part can reach the
blood directly due to the much higher capillary per-
meability within the myocardium than in skeletal
muscle (138).
The significance of diagnostic enzymology in he-
patic diseases is probably due to the extremely high
capillary permeability. Hepatic alkaline phosphatase
molecules for example probably pass freely through
the large openings in the sinusoidal endothelial lin-
ing and are transported out of the liver chiefly in si-
nusoidal blood, which flows more rapidly than liver
lymph (144).
Generally it seems that hepatic lymph derives the
bulk of its proteins from the plasma (145, 146, 147).
Even under physiological conditions several enzyme
activities in the thoracic duct lymph are several fold
higher than in plasma (51, 134). From these data
and from lymph flow the extent to which enzymes
are continuously added to the blood just by means of
lymphatic inflow can be calculated, e.g. creatine ki-
nase with a recirculation index of 2.07 per day and -
glutamyltransferase and lactate dehydrogenase with
0.88 and 0.66, respectively.
Actually these calculated exchange rates may be ev-
en somewhat higher because the dogs were anaes-
thetized and therefore lacked the physiological Stim-
ulation of lymph flow by physical activity.
Data from conscious humans, äs reported by Werner
(148), however, are of restricted value, because they
might be influenced by the pathologic conditions
which gave rise to the cannulation of the thoracic
duct.
If the concept of the significance of lymphatic trans-
port of enzymes holds true, one would expect that
the mere lymph flow change can alter enzyme activi-
ties 'in plasma. The most impressive example for a
physiological increase in lymph flow is physical ex-
ercise.
Animal experiments have demonstrated that even
during moderate excercise thoracic duct lymph flow
increases t wo and threefold (46, 50). This pheno-
menon exemplifies how an absolutely physiological
process affects enzyme activities in plasma just be-
cause the System of flux equilibria gets disturbed.
The most commonly used explanation for changes· of
enzyme activities in plasma during and after physical
exertion is an enzyme release from cells, due to a
relative transient hypoxia, which is believed to lead
to an increased permeability of the cellular mem-
brane for macromolecules caused by a depletion of
cellular energy (149, 150).
Thereby enzyme release from muscle cells should
contribute to the main part of elevated enzyme activ-
ities in plasma (150), whereas other authors attrib-
ute more importance to the liver (151, 152).
Further factors, which can contribute to changes of
enzyme activities in plasma are haemoconcentration
(153), intravascular haemolysis (154, 155) and the
type, intensity (154), duration (150), and extent of
the work executed (156).
All these studies performed in humans, however, are
phenomenological interpretations from enzyme ac-
tivities in plasma. Taking into consideration the
simpliest fundamentals of circulation physiology and
the proportions of the intravasal and interstitial dis-
tribution space, however, in that the latter is four-
fold greater than the former, it becomes questionable
whether during and after physical exercise a release
of enzymes from cells occurs at all. The following
concept of enzyme activity changes in plasma during
and after physical exertion is based mainly at experi-
mental findings and considerations by Friedel et al.
(134, 143, 153, 157) and our group (30, 51, 158)
and taking into consideration the major part of clini-
cal äs well äs experiinental observations by other au-
thors.
During physical exertion the System of flux equilibria
between the interstitial and the intravascular com-
partment becomes disturbed. The first acute effect is
a decrease in plasma volume, because of an in-
creased systemic blood pressure and consequently an
intravascular concentration of macromolecules in an
order of magnitude of 10-15%. In skeletal muscle,
this increased hydrostatic pressure leads to an in-
creased filtration of solution into the interstitium,
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thus causing an enhanced lymph flow from muscle
which is propulsed by the action of the tissue pumps
of the active working muscle. The lymph entering
the intravascular compartment contains enzymes,
which become concentrated because the capillary
membranes within skeletal muscle are almost imper-
meable to proteins, whereas fluid is filtered back at
nearly the same enhanced rate äs it flows into the
plasma.
The accumulated proteins and enzymes also slowly
get back into the interstitial space, but preferably in
such regions where the capillary permeability is high,
äs in the liver. They thereby also induce an increase
of lymph flow from the liver, because the organism
tries to keep the colloidosmotic equilibrium in bal-
ance.
For other organs the intravascular concentration of
macromolecules with an increasing colloidosmotic
pressure leads to a reduction of fluid filtration into
the interstitium and thus to a reduction in lymph
flow from these organs.
To which extent all these physiological mechanism
affect the plasma activity of a particular enzyme de-
pends on its lymph-plasma activity ratio, especially
for lymph from skeletal muscle. Since creatine ki-
nase in plasma originales mainly from skeletal mus-
cle and therefore has a .considerably higher lymph^
plasma activity ratio in muscle lymph, than plasma
proteins and other enzymes, it is not astonishing,
thät the most distinct increase in plasma activities
during and after exercise is usually found for this
particular enzyme.
It must be mentioned again, however, that due to the
proportions of the interstitial and intravasal space of
4:1, the concentfätion of macromolecules with a
lymph-plasma ratio less than one can rise consid-
erably in plasma during physical activity.
It is highly probable that the effect which physical
exertion has on enzyme activities in plasma is caused
mostly, if not totaliy by an alteration in the extracel-
lular distribution of cellular enzymes, so that the to-
tal extracellular activities do not change at all.
This Statement definitely does not imply that, during
exertipn^ there is äb$plutely rip enzyme release from
the active working muscle, a phenomenon whieh de^
pends, äs putlined at the beginning, on the duration
and type of the work executed. it calls in questiön,
however, the often Made assumption tfeät even the
short term general hypoxia, which occurs during
strenupus exercise, ean be the cause för an enzyme
release frpni cells of muscle and/or other organs. An
enzyme release on the basis of "blebbiiig" (159) is
ünlikely, considering the energy Status of muscle afr
ter tourniquet application of üp tp 2 h duration
(160-163).
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6. Enzymes in Different Lymphatics of Man and Various Animals (Tab. 1).
Tab. 1. Enzyme catalytic activity concentrations, protein and albumin concentration, lymph-plasma activity ratio and lymph flow from
different lymphatics in man, sheep, dog, cat, rabbit, guinea pig and rat.
The data were taken from the authors cited under Reference. ~ denotes, that values were estimated from figures.
Values are given s mean with Standard deviation (SD) or Standard error of the mean (SEM).
Units: Catalytic concentrations are given in U/l (lymph) or U/g (protein); the numbers in this column refer to following notes:
1. Sigma units/ml
2. Phenolphthalein released, μg/100 ml x h (at 37 °C)
3. Phenolphthalein released, μg/100 ml x h
4. Octopamine formed, nmol/ml x 20 min
5. p-Nitrophenol released, μg/ml x h
6. Phenolphthalein released, μg/ml x h
7. -Phenylethanolamine formed, μπιοΐ/ml x 20 min
8. Tyrosine, 10~5 mEq/h x g protein
9. />-Nitrophenol released, μιηοΐ/min x g protein
10. Phenolphthalein released, μg/2 h x g protein
11. 4-Nitrocatechol released, mg/h x g protein
12. Berger-Broida - U/ml
13. Nucleotides released, mg/ml x h
14. ΔΑ280 nm/ml x unit time
15. Counts/min per hour










6.1 Ductus thoracicus lymph
Alkaline phosphatase 3.1.3.1
Aspartate aminotransferase 2.6. l. l





































775 ±15.3 SD U/I













2.7.3.2 Data in percent
1.1.1.27 change





0.09 ± 0.05 SD
803 ±334 SD
3.2.1.1 1585 ±317 SD U/I














































Data from patients with biliary man 164
obstruction
Data from patients with liver man 165
cirrhosis and from 2 normal
persons
Enzymes in lymph after man 166
administration of a combination
of coumarin and rutin sulphate
Evidence that intestinal alkaline man 167
phosphatase enters the
circulation via lymph
The biochemical composition of man 148
the human thoracic duct lymph
is presented
Protective effect of the lymphatic man 168
System due to alcohol
14.5 ± 3.8 Enzymes from muscle are
μΐ/min transported from the interstitial
x kg into the intravasal compartment




In both haemorrhagic and endo- dog 169
toxin shock, lysosomal enzymes
gain access to the circulation via
the lymphatics
Protective effect of a combina-
tion of coumarin and rutin sul-
phate on canine experimental
pancreatitis
dog 170
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Significance of the lymphjrfic
System in resorption of enzymes
frorn the damaged kidney
Lymph is prpbably not the main






























































1.1.1.27 6.5 ±4.4 SEM
2.6.1.1 16.1 ±3.4



























1.1.1.27 36.4 ±5.7 SD U/l
1.1.1.14 3.4 ±0.7 SEM U/l
1.1.1.27 33.2 ±5.9 U/l
1.1.1.32 96.3 ±15.6 U/l
1.4.1.3 2.3 ±0.9 U/l
2.6.1.1 18.6 ±2.8 U/l
enzymes into the circülating
blood in haemorrhagic shock
More direct indication in lymph dog 173
than in blood for the degree of
hepatosplanchnic cellular impair-




In drained dogs the values of the dog
enzymes-in blood, urine andperi-
toneal exsudate were lowered
aftef an acute pancreatitis
174
U/l 4.4-5.7 0.59- During haemorrhagic shock the dog 175
0.62 ml/kg majority of lysosomäl enzymes
x 15 min released from the intestine gain
access to the blood via lymph











ml/min prednisolone on total accumula-
tion of serum and lymph acid
phosphatase in haemorrhagic,
endotoxic and cardiogenic shpck
Increased activities of lactate dog 177
dehydrogenase and malate dehy-
drogenase after 30 min ofrenal
ischaemia and of lactate dehydro-
genase, malate dehydrogenase
and alkaline phosphatase after 2
hours of renal ischaemia
Organ distribution and activities dog 178
in body fluids of these enzymes
·=- Lactate dehydrogenase and dog 40
aspartate aminotransferase feach
the circülating blood directly
from the intraeellular compart-
ihent in contrast to creatine
kinase
10—12 The increaseof creatine kinase, dog · 39
ml/min aspartate aminotransferase and
lactate dehydrogenase in plasma
during 30 min electrical müscle
Stimulation were not altered by
df aining lymph
0.46 — Lactate dehydrogenase is trans- dog 38
ported from the tissues by lym-
phatics äs well äs by blood
capillaries
35 /kg A significantly higher lymph- dog 134
x min plasma ratio for sorbitol dehydro-
genase, malate dehydrogenase,
aspartate aminotransferase and
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Experimental conditions; Spe- Ref.
conclusions cies
suggests a predominantly lym-
phatic pathway, whereas for the
other enzymes a partly lymphatic
entry into the blood is proposed.
There is a close relationship



















551 ±306 SD U/l
3.1.3.1 -180
3.1.3.1 -
enzymes and their lymph-plasma
ratio
© —1.05 2.2ml/ Protective effect of lymph diver- cat 179
kg X h sion in haemorrhagic shock
because of lymphatic transport
of lysosomal enzymes into the
blood
0.64 2.2 ± 0.6 Lymphatic transport of dopamine cat 180
ml/h ß-hydroxylase, although a direct
entry cannot be excluded
always —2.5 Lymphatic pathway is not rabbit 181
< l ml/h essential for the increased levels
of acid hydrolases in the plasma
^ following haemorrhage
2.38 0.61 ± No activity in lymph after rat 182
0.11 ml/ Stimulation of the damaged
45 min pancreas by secretin and
pancreomyzin
U/l —1.0 0.6 ml/h Direct entry of liver alkaline rat 144
phosphatase by way of the
hepatic sinusoids
U/l — 0.6 ml/h Hepatic alkaline phosphatase rat 183
enters the serum directly by





















































































0.31 ± Determination of various rat
0.02 ml/ components in lymph and
l O O g x h plasma
— Right duct lymph contained man
significant amount of heart
lymph in only 60% of patients
operated upon with open heart
surgery
— Efflux of enzymes in lymph and man
serum after coronary perfusion
and ischaemic arrest
— Significant correlation between man
— activity in lymph and serum
— No change of enzyme activity in dog
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2.7.3.2 1357 ±306 SD
1.1.1.27 785 ±250









2.6.1.1 31.0 ±12.7 SD





3.1.3.2 0.08 ±0.01 SD























Lymph/ Lymph Experimentalconditions; Spe-
plasma flow conclusions cies
ratio
• r
4.98 - Determination ofvarious dog
13.1 constituents in cardiac lymph
4.04 2.4 ml/h Increase in lymph and dog
pericardial fluid but not in
plasma after ligation
- - Increase to 40 (creatine kinase), dog
1720 (lactate dehydrogenase)
and 4930 (malate dehydrogenase)
60 min after 90 min ischaemia
- - Increase to 10000 (creatine dog
kinase), 5000 (lactate dehydro-
genase), 10000 (malate dehydro-
genase), 1 000 (aspartate amino-
transferase) and 600 (alanine
aminotransferase) after 120 min
ischaemia
4.31 — After experimental myocardial dog
0.77 infarction the enzyme escape via
3.10 heart lymph increased, except
2.25 fof acid phosphatase
0.55
1.0
— — Protectiveeffectofsteroidson dog
increase of acid phosphatase '
- 1.2 ml/h After ligation ofthec ronary dog













Phosphodiesterase I 3.1.4.1 1.8 ®
Nucleotide pyrophosphatase 2.6.1.9 3.4 ®







2.6.1.1 54.9 ±29 SD U/l -
Creatine kinase 2.7.3.2 - U/l -
Lactate dehydrogenase 1.1.1.27 245 ±34 SEM U/l 6.7
Malate dehydrogenase 1.1.1.32 235 ± 19 U/l 3.1
Creatine kinase 2.7.3.2 0.9 ± 0.2 U/l 1.4
Aspartate aminotransferase 2.6.1.1 58 ± 24 U/l 7.2
Alkaline phosphatase 3.1.3.1 - U/l l








fold and aspartate amino-
transferase and lactate dehydro-
genase feil to roughly half the
control value
No protective effect of methyl- dog 88
prednisolone on increase of acid
phosphatase
Organ distribution and activities dog
in body fluids of these enzymes
178
Decreaseof aspartate amino- dog 193
transferase after thrombin
infusion
2.5-fold increase in lymph and 3 dog 194
to 4-fold in plasma above control
values after ischaemia
Lymphaticactivityof lactate dog 195
dehydrogenase, malate dehydro-
genase, aspartate amino-
transferase and creatine kinase
increased after occlusion of the
cororiary artery. Plasma levels
rise later. Alkaline phosphatase



















The time course of activity
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Significant amount of aspartate
aminotransferase reached the
blood via lymph
20-30% of liberated enzymes
after infarction reach the blood
via the lymphatic System
Increase after short term
ischaemia (20 min) in lymph
from conscious animals
Acid phosphatase increased 30%
and creatine kinase rose 62%
after 2 h occlusion of the left
coronary artery
Only slightly increased activities
in the group with congestive
heart failure
Under physiological conditions
activities of all enzymes in lymph
are higher than in serum.
Including flow rates of myo-
cardial lymph and coronary blood
enzyme transport, rate of lymph
after infarction is about 15%
Marked increase after 90 min
ischaemia
Haemorraghic shock: increase of
ß-glucuronidase in plasma, not
in lymph, no lung injury.
Endotoxin shock: increase of
both enzymes in lymph and
plasma; severe lung injury
After 50% full-thickness burn
increase of both enzymes in
plasma and lymph; time course




enzyme by the lung into lymph.
No rise in plasma
Haemorrhagic shock produced a
systemic cellular injury reflected
in an increased plasma lactate
dehydrogenase activity, but not
in lung lymph
The degree of systemic and
pulmonary injury after endotoxin
shock corresponds to the increase
in plasma and lymph enzyme
activity, respectively. The
mechanism of injury and activity
increase appears to be different
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Tab. 1. Continued.
Analyte EC Value Unit Lymph/ Lymph Experimental conditions; Spe- Ref.





2.7.3.2 31.7 ±6.2 SD U/l 0.7
•68. l ±4.9 g/l 0.8







































increased plasma levels of acid
hydrolases in haemorrhagic
shock. Lymphatic pathway not







After obstructionofsmall dog 206
intestine or bile duct no marked
increase in lymph or serum
enzyme levels were npted
Following pancreatectomy there dog 207
is a progressive decline in the
activities in serum and hepatic
lymph
Comparison of lactate dehydro-






















































































































6.8 ml/ After obstruction of small
30 min intestine or bile no marked
increase in lymph or serum
were noted
6.8 ml/ Fpllpwing päncreätectqrny there
30 min is a progressive decline öf both
enzymes in the serum and lymph
— Lipase was absorbed by the
duodenum irito lymphatics
— Comparison of lactate
dehydrogenase contents of
various lymph vessels
— Acid phosphatase was added to
the cäpülary filtrate at ä regional
tissue level, whereas both other
enzymes in lymph derived by
Filtration from the blood plasma
on a molecular weight basis
0.55 ± Elevation of sialyltransferäse,
0.05 ml/ alkaline phosphatase and lactate
10min dehydrogenase after colchicine
treatment, whereas maltase and
sucrase remain unchanged















- rabbit higher than in guinea pig. .guinea
-
-
This difference was eveii rhofe
pronounced after heparin
injection
— Role of intestinal alkaline phos-










Kaum ein anderes UV/VIS-
Spektrophotometer gibt Ihnen die
Sicherheit für Kinetikmessungen im
klinischen und pharmazeutischen
Bereich wie die Geräte der
Lambda-Serie.




und den für die Qualitätssiche-
rung wichtigen Größen LINEARI-
TÄTSFAKTOR und STANDARD-
ABWEICHUNG.
Damit Sie die Ergebnisse richtig
. beurteilen können!
2. Vollständiger Ausdruck aller
Analysenparameter, damit Sie





CUR WL « 34 .
LflG - 69 SEC
CflLS = 06
DEL « 38 SEC
EN FRC » 57
REC OUT » BBS
ORD HRX « 1.
ORD MIN = a.eee
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Ausdruck der Analysenergebnisse und
Analysenparameter, EA = Enzymaktivität in U/ml,
DA = Extinktionsandefung in E/min,
LF = Linearitätsfaktor, SD = Standardabweichung.
3. Mit dem Gitter-Monochromator
sind Sie nicht auf bestimmte
Wellenlängen festgelegt, son-
dern können jeweils im Maximum
messen oder sogar registrieren.
4. Zuverlässigkeit in der Bedienung
durch Methodenspeicher-auch
wenn die Netzspannung einmal
ausfällt.
5. Die Lambda 1-, 3- oder
5-Systeme können Sie an Ihre
Anforderungen anpassen, vor
allem dann, wenn es um wech-
selnde Aufgabenstellungen geht.
Für nähere Informationen wenden
Sie sich bitte an
Bodenseewerk
Perkin-Elmer & Co GmbH,





Pathobiöchemie - Klinik - Methodik
Von Oswald Müller-Plathe
Chefarzt des Zentrallaboratoriums am Allgemeinen Krankenhaus
Altona in Hamburg
2., überarbeitete und erweiterte Auflage
1982.294 Seiten, 89 Abbildungen, 42 Tabellen, 15,5 23 cm,
kartoniert DM 79,-
Klinische Chemie in Einzeldarstellungen, Band l
„In den neuen Jahren seit Erschei-
nen der ersten Auflage, mit der
das seinerzeit weit verstreute
Wissen auf dem Gebiet der Säure-
BaseivPhysiologie und der Blut-
gasanalytik zusammengefaßt
wurde, hat dieser Sektor eine
enorme Weiterentwicklung erfah-
ren.
Die 2. Auflage vermittelt einen
Überblick über den gegenwärtigen
pathobiochemischen und klinischen
Wissensstand auf diesen Gebieten.
Auch die fnethodisch4echnQ-
logische Entwicklung der Blutgas*
analytik wird berücksichtigt,
die heute aus wenigen Mikrolitern
Blut in kürzester Frist einen
kompletten Blutgas- und Säure^
Basen-Status zu erstellen gestattet.
Die Funktionsprinzipien der
Geräte, Ursachen, Prophylaxe und
Beseitigung von Störungen sowie
Möglichkeiten der Qualitätssiche-






















































































































































































































































12.8 ± Distribution and transport of cell
1.3 μΐ/min enzymes within the extracellular
space. Cell enzymes are trans-
ported preferably by the
lymphatics. There is a close
relationship between the
molecular weight of enzymes
and their lymph-plasma ratios
— Lactate dehydrogenase content
in various lymph vessels
— Similar pattern in capsular and
% hilar lymph indicate a pre-
dominantly cortical origin of
both lymph samples
Hilar lymph was sampled. After
30 min of renal ischaemia there
was a marked increase of cyto-
plasmic enzymes in lymph and
urine which after 2 hours of
ischaemia was followed by a rise




9—10.5 Hypoxia for one hour on the
ml/15 min bind leg muscle does not
pr voke release of enzymes.
Enzymes from muscle have to be
transported into the blood by
lymph flow and not via a direct
interstitial-venous entry
·=- A two^cqmpartement model of
tissue fluid is presented
— Superficial leg lymph vessel;
in lymph draining skin and
subcutaneous tissue only a small
admixture of locally released
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Efferent popliteal lymph vessel;
indication that acid phosphatase
was added to the capillary fil-




Creatiiie kinase 2.7.3.2 ~ 50 U/l 3.6
Lactatedehydrogenase 1.1.1.27 -300 U/l 9.0
Aspartate aminotransferase 2.6.1.1 ~ 30 U/l 2.7
Alanine aminotransferase 2.6.1.2 ~ 22 U/l 0.6
Aldolase 4.1.2.13 ~ 20 U/l 3.3
Adenylate kinase 2.7.4.3 ~ 60 U/l 3-8
Malate dehydrogenase 1.1.1.32 -300 U/l 6.9
Leucine aminopeptidase 3.4.11.1 — 5 Ü/l 0.5
Alkaline phosphatase 3.1.3.1 ~ 38 U/l 1.0
Choline esterase \ \ 3.1.1.8 -300 U/I 0.2






















3.1.3.2 20.8 ±1.5 SEM ©
3.2.1.31 1.5 ±0.2 ©
1.1.1.27 336 ±26 U/l
21.8 ±0.9 g/l
•1.1.1.27 445 ±75 SD











Lactate dehydrogenase 1.1.1.27 249
Aspartate aminotransferase 2.6. l. l 38
Alanine aminotransferase 2.6.1.2 4
ß-Glucuronidase 3.2.1.31 7150
Acid phosphatase 3.1.3.2 80
Protein 29
Lactatedehydrogenase 1.1.1.27 -
Aspartate aminotransferase 2.6.1. l —





















frorn the blood plasma compart-
ment on a fnolecular weight basis
3.0ml/ Femoral deep lymphätic; ffofn dog 135
15min lymph-plasma fatios of enzymes
(all were significantly greater
than that of cholirie esterase -
an enzyme which is exclüsjvely
synthesized in liver and which
may get into the lymph only by
a limited escape in the capillary
area) it is coricluded that cellular
enzymes have to be tfansported
into the intravasculär space by
lymph flow, and scarcely via a
direct entry across capillaries
— Saphenous lymph vessel dog 38
16 ±3 Süperficial and deep femoral cat 110
/min lymph vessel i the activities of
aspartate aminotransferase were
about the same; alänine amino-
transferase and lactate dehydro-
genase somewhat lower, that of
acid phosphatase and ß-glueu-
ronidase was somewhat higher
than those usually present in
plasma
— Hind paw; no appreciable rabbit 215
release of lysosomal enzyme
after 4 hours tourniquet, whereas
lactate dehydrogenase increased
in lymph
11.4 ± 2.4 Fefnoral lymph vessel; the effect rabbit 216
/min of anti-inflammatory agents on
the changes in local lymph after







Femoral lymph vessel; limbs
were injured by burning at 80 °C




Muscle lymph; total feriipral rabbit 112
flow was 21.5 ± 5 ul/min, while
muscle lymph flow was 5.3 ± 1.
Increase of enzymes in muscle
























Femoral lymph vessel ; various rabbit
thermal injuries were investigated
for changes in lymph and plasma
<
111
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